Rainin Foundation awards $750,000 for IBD research
Friday, 17 February 2017 09:31
On 10 Feb 2017, the Kenneth Rainin Foundation announced that it has awarded $750,000 for Inflammatory Bowel Disease (IBD) research through its Synergy Award program. The Rainin Foundation funds scientific projects that have the potential to yield transformative discoveries and major insights into predicting and preventing IBD. Further details of the projects and awards can be found in their blog. The Synergy Awards are intended to foster collaboration. The Synergy Award programme is one of three grant programmes the Rainin Foundation offers for IBD-related research.
NIHR Rare Disease Day Cambridge Lecture
Thursday, 16 February 2017 14:17
This free lecture (on 28 February 2017, from 6pm-9pm, in Cambridge) will include updates about rare disease research, as well as insights from speakers directly affected by rare diseases. There will be the opportunity to talk with researchers and professionals and connect with patients and carers. For more information and to book, go to the Eventbrite booking site. Rare Disease Day will be marked for the 10th year on 28 February 2017. People living with or affected by a rare disease, patient organisations, politicians, carers, medical professionals, researchers and industry will come together in solidarity to raise awareness of rare diseases.
TRITON grant announcement
Wednesday, 15 February 2017 17:21
Professor Spiller and a team of experts from the Neurogastroenterology & Motility Section of the British Society of Gastroenterology who are based in 12 major research centres in the UK have been awarded a £2.1M grant from the National Institute of Health Research Efficacy and Mechanism Evaluation (NIHR EME) Programme to perform a clinical trial entitled "Treatment of IBS with diarrhoea with Titrated Ondansetron (TRITON)”. The trial will be coordinated from the Leeds Clinical Trials Research Unit and the mechanistic studies will involve specialist centres in Leeds, University College London and Barts and the London Hospital. Recruitment is expected to start in autumn 2017.
The trial offers a great opportunity for two specialist registrars to obtain a higher degree in the rapidly expanding field of neurogastroenterology. The trial will include studies of how ondansetron affects bowel motility and sensitivity. Understanding how ondansetron works will improve our ability to predict who will respond and will inform the development of new treatments for this common and distressing condition. One registrar will be based at QMC, Nottingham and the other at QMUL, London; both are expected to start their fully supported OOP work in September 2017. The posts will be advertised soon with full information on how to apply.
The BBC are looking for expert women in science and health
Wednesday, 15 February 2017 10:59
In conjunction with BBC News, the BBC Academy is holding a free media familiarisation day for women with particular expertise interested in appearing on television, radio and online as contributors or presenters. If you're interested, see the full details and how to apply and don't forget to let us know if you're successful!
Page 3 of 35